Literature DB >> 12752219

Routine genotyping of human papillomavirus samples in Denmark.

Thomas Johnson1, Karin Bryder, Sylvie Corbet, Anders Fomsgaard.   

Abstract

In order to examine a sensitive unbiased consensus PCR with routine sequencing for HPV typing, we analysed Danish male and female patients suspected of having an HPV infection. We used the well-characterised nested PCR setting with MY09/MY11 and GP5+/GP6+ primers, followed by routine cycle sequencing. Of 1283 clinical samples from female patients based on suspected HPV infection, we found 379 (29%) negatives and 894 (70%) positives. Samples containing >5000 HPV copies/ml were genotyped by sequencing. Of the 552 HPV genotyped samples from women >15 years of age, 398 were characterised as high-risk types and the remaining 154 as low-risk types. The most commonly found high-risk types were HPV-16, HPV-31, HPV-33, HPV-18, HPV-58, and HPV-52, and the most commonly found low-risk types were HPV-6, HPV-53 and HPV-11. In addition, we observed that other typing assays could not perform as sensitively or accurately as the nested PCR/cycle sequencing method used in this study. For instance, 87 out of 552 genotyped samples could not have been typed correctly in the Hybrid Capture II assay. Of these 87 samples, 46 (53%) were considered as high-risk types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752219     DOI: 10.1034/j.1600-0463.2003.t01-1-1110204.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens.

Authors:  Véronique Fontaine; Corinne Mascaux; Christine Weyn; Aurore Bernis; Nathalie Celio; Philippe Lefèvre; Leonard Kaufman; Christian Garbar
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

2.  Hierarchical assessment of host factors influencing the spontaneous resolution of hepatitis C infection.

Authors:  Paola Jocelan Scarin Provazzi; Livia Maria Gonçalves Rossi; Bruno Moreira Carneiro; Valeria Chamas Miura; Plinio Cesar Rodrigues Rosa; Lucas Rodrigues de Carvalho; Stephane Tereza Queiroz de Andrade; Roberta Maria Fachini; Rejane Maria Tommasini Grotto; Giovanni Faria Silva; Carlos Roberto Valêncio; Paulo Scarpelini Neto; José Antonio Cordeiro; Mauricio Lacerda Nogueira; Paula Rahal
Journal:  Braz J Microbiol       Date:  2018-12-04       Impact factor: 2.476

3.  Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk.

Authors:  M Ortiz; M Torres; L Muñoz; E Fernández-García; J Canals; A I Cabornero; E Aguilar; J Ballesteros; J Del Amo; A García-Sáiz
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.

Authors:  Sin Hang Lee; Jessica S Vigliotti; Veronica S Vigliotti; William Jones
Journal:  Cancers (Basel)       Date:  2014-10-02       Impact factor: 6.639

5.  Validation of human papillomavirus genotyping by signature DNA sequence analysis.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Jessica S Vigliotti; Suri Pappu
Journal:  BMC Clin Pathol       Date:  2009-05-22

6.  Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Suri Pappu
Journal:  J Clin Pathol       Date:  2009-10-26       Impact factor: 3.411

7.  Inter-laboratory validation of PCR-based HPV detection in pathology specimens.

Authors:  Iver Petersen; Christiane Schewe; Karsten Schlüns; Manfred Dietel; Norbert Speich; Christoph Schmitt; Magdolna Bollmann; Karl Sotlar; Burkhard Bültmann; Maria T Dours-Zimmermann; Barbara Padberg; Dieter R Zimmermann
Journal:  Virchows Arch       Date:  2007-07-10       Impact factor: 4.535

8.  Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Suri Pappu
Journal:  BMC Womens Health       Date:  2009-04-09       Impact factor: 2.809

9.  Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Jessica S Vigliotti; Suri Pappu
Journal:  Infect Agent Cancer       Date:  2007-06-05       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.